Related Experiment Video
Updated: Aug 13, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Long-term incidence of infective endocarditis among patients with congenital heart disease
Eva Havers-Borgersen1, Jawad H Butt1, Lauge Østergaard1
1Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Insights
Patients with congenital heart disease (CHD) face a significantly higher risk of infective endocarditis (IE). This study highlights specific CHD types and patient factors that increase IE incidence, emphasizing the need for updated preventive guidelines.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Congenital heart disease (CHD) patients have a lifelong elevated risk of infective endocarditis (IE).
- Knowledge regarding IE risk variation across different CHD types is limited.
- This study investigates IE incidence across diverse CHD subtypes.
Purpose of the Study:
- To compare the risk of IE in patients with congenital heart disease versus the general population.
- To identify specific types of CHD associated with a higher incidence of IE.
- To examine factors influencing IE risk in CHD patients.
Main Methods:
- An observational cohort study utilizing Danish nationwide registries.
- Identification of CHD patients born between 1977 and 2018, followed until 2018.
- Comparative analysis of IE risk using Cox-regression, stratified by CHD type and patient factors.
Main Results:
- CHD patients (n=23,464) had a substantially higher IE incidence (5.2/10,000 person-years) than controls (0.02/10,000 person-years).
- Highest IE incidence observed in tetralogy of Fallot, complex heart chamber malformations, atrioventricular septal defects, and valve defects.
- Associated IE risk factors in CHD patients included male sex, cyanosis, cardiac prostheses, chronic kidney disease, and cardiac implantable electronic devices.
Conclusions:
- Congenital heart disease patients exhibit a significantly increased incidence of infective endocarditis compared to the general population.
- Specific CHD subtypes and patient comorbidities are linked to heightened IE risk.
- Enhanced preventive strategies and updated clinical guidelines are crucial for managing IE risk in the growing population of CHD survivors.
Background:
Patients with congenital heart disease (CHD) are at lifelong high risk of infective endocarditis (IE). The risk of IE presumably differs among different CHD, but little knowledge exists on the area.
Methods:
In this observational cohort study, all CHD-patients born in 1977 to 2018 were identified using Danish nationwide registries and followed from the date of birth until first-time IE, emigration, death, or end of study (December 31, 2018). The comparative risk of IE among CHD-patients vs age- and sex-matched controls from the background population was assessed. The risk of IE was stratified according to the type of CHD and factors associated with IE including sex and relevant time-varying coefficients (ie, cyanosis, cardiac prostheses, diabetes mellitus, chronic kidney disease, and cardiac implantable electronic devices) were examined using Cox-regression analysis.
Results:
A total of 23,464 CHD-patients (50.0% men) were identified and matched with 93,856 controls. During a median follow-up of 17.7 years, 217(0.9%) CHD-patients and 4(0.0%) controls developed IE, corresponding to incidence rates of 5.2(95%CI 4.6-6.0) and 0.02(95%CI 0.01-0.1) per 10,000 person-years, respectively. The incidence of IE was greatest among patients with tetralogy of fallot, malformations of the heart chambers (including transposition of the great arteries, univentricular heart, and truncus arteriosus), atrioventricular septal defects, and heart valve defects. Factors associated with IE among CHD-patients included male sex, cyanosis, cardiac prostheses, chronic kidney disease, and cardiac implantable electronic devices.
Conclusions:
CHD-patients have a substantially higher associated incidence of IE than the background population. With the increasing longevity of these patients, relevant guidelines concerning preventive measures are important.
More Related Videos
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

